A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

BACKGROUND: Ciclosporin is approved for the treatment of atopic dermatitis (AD) in dogs and has been shown to be safe and effective. Placebo-controlled studies suggest that oclacitinib is a safe and effective alternative therapy. HYPOTHESIS/OBJECTIVES: To evaluate the efficacy and safety of oclaciti...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Peter R, King, Vickie L, Davis, Kylie R, Cosgrove, Sallie B, Stegemann, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Scientific Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365754/
https://www.ncbi.nlm.nih.gov/pubmed/25496303
http://dx.doi.org/10.1111/vde.12186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365754/
https://www.ncbi.nlm.nih.gov/pubmed/25496303
http://dx.doi.org/10.1111/vde.12186

Ejemplares similares